Form 4 Tracker
Benjamin Looker

Chief Legal Officer; General Counsel · 5 filings · Latest: Jul 13, 2026

Esperion Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ESPR
Benjamin LookerChief Legal OfficerJun 17, 2026
Sale
$3.1611,824$37.3K667,524
ESPR
Looker Benjamin—Jun 17, 2026
Proposed Sale
$3.1511,824$37.3K—
ESPR
Benjamin LookerChief Legal OfficerMar 17, 2026
Sale
$2.705,708$15.4K679,348
ESPR
Looker Benjamin—Mar 17, 2026
Proposed Sale
$2.705,708$15.4K—
ESPR
Benjamin LookerGeneral CounselJan 20, 2026
Sale
$2.881,689$4.9K384,216
ESPR
Looker Benjamin—Jan 20, 2026
Proposed Sale
$2.881,689$4.9K—
ESPR
Looker Benjamin—Dec 17, 2025
Proposed Sale
$3.676,517$23.9K—
ESPR
Looker Benjamin—Oct 17, 2025
Proposed Sale
$2.621,248$3.3K—
ESPR
Looker Benjamin—Sep 17, 2025
Proposed Sale
$2.806,267$17.6K—
ESPR
Looker Benjamin—Jul 17, 2025
Proposed Sale
$1.131,304$1.5K—
ESPR
Looker Benjamin—Jun 17, 2025
Proposed Sale
$1.156,422$7.4K—